This is a routine investor presentation with no new material information beyond what was disclosed in the Q1 2026 earnings release on May 14, 2026. The reaffirmed guidance and strong Q1 growth trajectory support the current narrative, but no catalyst for near-term price movement is present. Monitor upcoming quarterly results for execution against the 7-10% long-term growth targets.
Price Chart
Executive Summary
Aveanna Healthcare filed an 8-K furnishing a May 2026 investor presentation that reiterates FY2026 guidance of $2.56B-$2.58B revenue and $328M-$332M Adjusted EBITDA, alongside Q1 2026 results showing 15.9% YoY revenue growth to $647.9M and 25.2% Adjusted EBITDA growth to $84.4M. The presentation is a routine strategic update with no new material disclosures beyond previously reported Q1 earnings.
Key Facts
- FY2026 revenue guidance reaffirmed at $2.56B-$2.58B
- FY2026 Adjusted EBITDA guidance reaffirmed at $328M-$332M
- Q1 2026 revenue of $647.9M, up 15.9% YoY from $559.2M
- Q1 2026 Adjusted EBITDA of $84.4M, up 25.2% YoY from $67.4M
- Q1 2026 operating cash flow of $4.3M, a $12.9M improvement YoY
- Total liquidity of $524.8M including $189.3M cash and $225.5M revolver availability
- Total variable rate debt of $1,483M as of April 4, 2026
- Presentation includes long-term growth targets: 7-10% total growth with 3.5-4.5% core organic growth
Financial Impact
No new financial data beyond previously reported Q1 2026 results; FY2026 guidance unchanged
Risk Factors
- High leverage with $1,483M variable rate debt exposes to rising interest costs despite hedging
- Free cash flow remained negative at -$3.8M in Q1 2026 despite operating cash flow improvement
- Gross margin declined to 31.7% in Q1 2026 from 32.8% in Q1 2025, indicating cost pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-225430 |
| Document: avah-ex99_1.htm | 0001193125-26-225430 |
| Document: 0001193125-26-225430-index-headers.html | 0001193125-26-225430 |
| Document: 0001193125-26-225430-index.html | 0001193125-26-225430 |
| Document: 0001193125-26-225430.txt | 0001193125-26-225430 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 24d ago | 8-K | $12.37 $12.21 | ▼ −1.29% | ▼ −1.72% | $12.70 (+2.71%) |
Aug 24, 2026 9w ago | Insider Cluster | $13.59 $13.46 | ▲ +0.96% | ▲ +0.42% | $12.70 (+6.51%) |
Aug 24, 2026 9w ago | Insider Cluster | $13.59 $13.46 | ▲ +0.96% | ▲ +0.42% | $12.70 (+6.51%) |
Aug 24, 2026 9w ago | 424B4 | $13.70 $13.42 | ▲ +2.04% | ▲ +2.51% | $12.70 (+7.26%) |
Aug 20, 2026 9w ago | Press Release | $13.16 $13.32 | ▼ −1.22% | ▼ −0.74% | $12.70 (+3.46%) |
Aug 9, 2026 11w ago | Institutional Cluster | $9.46 $12.69 | ▲ +34.14% | ▲ +34.19% | $12.70 (+34.30%) |
Jul 2, 2026 16w ago | Insider Cluster | $9.10 $9.82 | ▼ −7.91% | ▼ −6.98% | $12.70 (−39.62%) |
Jun 30, 2026 16w ago | 144 | $8.86 $9.60 | ▼ −8.35% | ▼ −8.09% | $12.70 (−43.40%) |
Jun 5, 2026 20w ago | Insider Cluster | $6.68 $7.09 | ▼ −6.14% | ▼ −5.57% | $12.70 (−90.19%) |
Jun 3, 2026 20w ago | 144 | $6.63 $7.00 | ▼ −5.58% | ▼ −8.13% | $12.70 (−91.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers